Parents consider lawsuit against Serum Institute of India after daughter’s death following Covishield dose

Following the admission in a court by the British pharmaceutical firm AstraZeneca that their vaccination can have uncommon side effects, the parents of a woman who allegedly died after taking Covishield are considering suing the Serum Institute of India (SII).

The Serum Institute of India produced Covishield, a medication created by AstraZeneca and Oxford University that was widely used in India.

Karunya, the daughter of Venugopalan Govindan, passed away in July 2021 following her Covishield vaccination. Nonetheless, the government-appointed national committee found insufficient evidence to conclude that the vaccine was the cause of her death.

A few parents have already filed a lawsuit alleging that their children’s deaths were caused by the vaccination. The government and the authorities who approved the vaccine were the targets of the petition. In those cases, the Serum Institute was not a party.

Also Read: AstraZeneca admits Covishield may lead to rare side effects

This is the result of AstraZeneca’s admission in court documents that a rare adverse effect of their vaccination could be reduced platelet count and blood clotting. AstraZeneca is being sued in a class-action case in the UK.

Global distribution of the Oxford-AstraZeneca Covid vaccination was conducted under various trade names, including “Covishield” and “Vaxzevria.”

Jamie Scott filed the claim in the UK after getting the AstraZeneca vaccine in April 2021 and suffering lifelong damage to the brain.

In the UK, the AstraZeneca-Oxford vaccination is no longer given out because of safety concerns. Although it has been demonstrated by independent tests to be successful in fighting COVID-19, the emergence of uncommon side effects has sparked regulatory attention and legal action.